Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADAM PHILLIP GORDON BRAUN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1356831317
CMS profile
8892379
Location
PORTER RANCH, CA

General Payments · PY2022–2024

$2,469.64

  • Reported across 27 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,554.59

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,029.59 16
Consulting Fee $525.00 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $109.25 1
PY2023 $805.80 9
PY2024 $1,554.59 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $125.62 11/25/2024 Food and Beverage Undisputed 01/23/2026 1093992235 CMS
AstraZeneca Pharmaceuticals LP $525.00 08/26/2024 Consulting Fee Undisputed 01/23/2026 1104244355 CMS
BeiGene USA, Inc. $28.72 10/31/2024 Food and Beverage Undisputed 01/23/2026 1120855516 CMS
GENZYME CORPORATION $49.16 05/28/2024 Food and Beverage Undisputed 01/23/2026 1139919860 CMS
Ipsen Biopharmaceuticals, Inc $121.18 05/31/2024 Food and Beverage Undisputed 01/23/2026 1091984109 CMS
Janssen Biotech, Inc. $32.38 05/02/2024 Food and Beverage Undisputed 01/23/2026 1078339508 CMS
JAZZ PHARMACEUTICALS INC. $26.80 01/24/2024 Food and Beverage Undisputed 01/23/2026 1150211419 CMS
JAZZ PHARMACEUTICALS INC. $137.63 05/18/2024 Food and Beverage Undisputed 01/23/2026 1150211421 CMS
JAZZ PHARMACEUTICALS INC. $123.12 12/07/2024 Food and Beverage Undisputed 01/23/2026 1150211417 CMS
Karyopharm Therapeutics Inc. $17.90 04/22/2024 Food and Beverage Undisputed 01/23/2026 1145527541 CMS
Merck Sharp & Dohme LLC $22.18 03/13/2024 Food and Beverage Undisputed 01/23/2026 1141931575 CMS
Novartis Pharmaceuticals Corporation $27.95 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086753027 CMS
Novartis Pharmaceuticals Corporation $30.39 12/11/2024 Food and Beverage Undisputed 01/23/2026 1086753029 CMS
PFIZER INC. $112.71 12/09/2024 Food and Beverage Undisputed 01/23/2026 1131180092 CMS
Rigel Pharmaceuticals, Inc. $120.21 05/15/2024 Food and Beverage Undisputed 01/23/2026 1145198591 CMS
SERVIER PHARMACEUTICALS LLC $24.82 04/25/2024 Food and Beverage Undisputed 01/23/2026 1147257720 CMS
SOBI, INC $28.82 09/03/2024 Food and Beverage Undisputed 01/23/2026 1141410406 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.